MAPT and neurodegenerative disease: Dysregulated EP300 activity has been linked to neurodegenerative diseases, particularly Alzheimer’s disease, where its hyperacetylation of tau, a microtubule-associated protein, has been observed, suggesting a potential mechanism for tauopathy, the aggregation of aberrant tau proteins in the brain [83].